1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Medicine
  4. Volume 71, 2020
  5. Article

Annual Review of Medicine

Volume 71, 2020

A Crucial Role for Diet in the Relationship Between Gut Microbiota and Cardiometabolic Disease

Abstract

Cardiometabolic disease (CMD), such as type 2 diabetes mellitus and cardiovascular disease, contributes significantly to morbidity and mortality on a global scale. The gut microbiota has emerged as a potential target to beneficially modulate CMD risk, possibly via dietary interventions. Dietary interventions have been shown to considerably alter gut microbiota composition and function. Moreover, several diet-derived microbial metabolites are able to modulate human metabolism and thereby alter CMD risk. Dietary interventions that affect gut microbiota composition and function are therefore a promising, novel, and cost-efficient method to reduce CMD risk. Studies suggest that fermentable carbohydrates can beneficially alter gut microbiota composition and function, whereas high animal protein and high fat intake negatively impact gut microbiota function and composition. This review focuses on the role of macronutrients (i.e., carbohydrate, protein, and fat) and dietary patterns (e.g., vegetarian/vegan and Mediterranean diet) in gut microbiota composition and function in the context of CMD.

Keyword(s): cardiometabolic disease, diet, dietary pattern, gut microbiota
Loading

Article metrics loading...

/content/journals/10.1146/annurev-med-062218-023720
2020-01-27
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/med/71/1/annurev-med-062218-023720.html?itemId=/content/journals/10.1146/annurev-med-062218-023720&mimeType=html&fmt=ahah

Literature Cited

  1. 1. 
    National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2002. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143–421
     [Google Scholar]
  2. 2. 
    Grundy SM, Cleeman JI, Daniels SR et al. 2005. Diagnosis and management of the metabolic syndrome in obesity. Circulation 6:4283–96
     [Google Scholar]
  3. 3. 
    World Health Organization Noncommunicable Diseases Country Profiles 2018 Geneva: World Health Organization https://www.who.int/nmh/publications/ncd-profiles-2018/en/
  4. 4. 
    Arora T, Bäckhed F. 2016. The gut microbiota and metabolic disease: current understanding and future perspectives. J. Intern. Med. 280:4339–49
     [Google Scholar]
  5. 5. 
    Sender R, Fuchs S, Milo R 2016. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164:3337–40
     [Google Scholar]
  6. 6. 
    Natividad JM, Agus A, Planchais J et al. 2018. Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome. Cell Metab 28:5737–49.e4
     [Google Scholar]
  7. 7. 
    Canyelles M, Tondo M, Cedo L et al. 2018. Trimethylamine N-oxide: a link among diet, gut microbiota, gene regulation of liver and intestine cholesterol homeostasis and HDL function. Int. J. Mol. Sci. 19:103228
     [Google Scholar]
  8. 8. 
    Zhao L, Zhang F, Ding X et al. 2018. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 1156:1151–56
     [Google Scholar]
  9. 9. 
    Cotillard A, Kennedy SP, Kong LC et al. 2013. Dietary intervention impact on gut microbial gene richness. Nature 500:7464585–88
     [Google Scholar]
  10. 10. 
    Le Chatelier E, Nielsen T, Qin J et al. 2013. Richness of human gut microbiome correlates with metabolic markers. Nature 500:7464541–46
     [Google Scholar]
  11. 11. 
    Aron-Wisnewsky J, Prifti E, Belda E et al. 2019. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut 68:170–82
     [Google Scholar]
  12. 12. 
    Org E, Blum Y, Kasela S et al. 2017. Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort. Genome Biol. 18:70
     [Google Scholar]
  13. 13. 
    Menni C, Lin C, Cecelja M et al. 2018. Gut microbial diversity is associated with lower arterial stiffness in women. Eur. Heart J. 39:252390–97
     [Google Scholar]
  14. 14. 
    David LA, Maurice CF, Carmody RN et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:7484559–63
     [Google Scholar]
  15. 15. 
    Deschasaux M, Bouter KE, Prodan A et al. 2018. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat. Med. 24:101526–31
     [Google Scholar]
  16. 16. 
    Maier L, Pruteanu M, Kuhn M et al. 2018. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555:7698623–28
     [Google Scholar]
  17. 17. 
    Lee SH, Yun Y, Kim SJ et al. 2018. Association between cigarette smoking status and composition of gut microbiota: population-based cross-sectional study. J. Clin. Med. 7:9282
     [Google Scholar]
  18. 18. 
    Santos-Marcos JA, Haro C, Vega-Rojas A et al. 2019. Sex differences in the gut microbiota as potential determinants of gender predisposition to disease. Mol. Nutr. Food Res. 63:e1800870
     [Google Scholar]
  19. 19. 
    David LA, Maurice CF, Carmody RN et al. 2014. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:7484559–63
     [Google Scholar]
  20. 20. 
    Erickson ML, Malin SK, Wang Z et al. 2019. Effects of lifestyle intervention on plasma trimethylamine N-oxide in obese adults. Nutrients 11:1179
     [Google Scholar]
  21. 21. 
    Quercia S, Turroni S, Fiori J et al. 2017. Gut microbiome response to short-term dietary interventions in reactive hypoglycemia subjects. Diabetes Metab. Res. Rev. 33:8e2927
     [Google Scholar]
  22. 22. 
    Wing RR, Phelan S. 2005. Long-term weight loss maintenance. Am. J. Clin. Nutr. 82:1222S–25S
     [Google Scholar]
  23. 23. 
    Kootte RS, Levin E, Salojärvi J et al. 2017. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab 26:4611–19.e6
     [Google Scholar]
  24. 24. 
    Salonen A, Lahti L, Salojärvi J et al. 2014. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J 8:112218–30
     [Google Scholar]
  25. 25. 
    Zeevi D, Korem T, Zmora N et al. 2015. Personalized nutrition by prediction of glycemic responses. Cell 163:51079–95
     [Google Scholar]
  26. 26. 
    Kovatcheva-Datchary P, Nilsson A, Akrami R et al. 2015. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. . Cell Metab 22:6971–82
     [Google Scholar]
  27. 27. 
    Vrieze A, Van Nood E, Holleman F et al. 2012. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143:4913–16.e7
     [Google Scholar]
  28. 28. 
    US Department of Agriculture, US Department of Health and Human Services 2010. Dietary Guidelines for Americans 2010 Washington, DC: US Gov. Print. Off. , 7th ed.. https://health.gov/dietaryguidelines/dga2010/dietaryguidelines2010.pdf
  29. 29. 
    World Health Organization 2018. A healthy diet sustainably produced. WHO Rep. WHO/NMH/NHD/18.12. https://www.who.int/nutrition/publications/nutrientrequirements/healhtydiet-information-sheet/en/
  30. 30. 
    Fardet A, Rock E. 2014. Toward a new philosophy of preventive nutrition: from a reductionist to a holistic paradigm to improve nutritional recommendations. Adv Nutr 5:430–46
     [Google Scholar]
  31. 31. 
    Willet W. 2013. Nutritional Epidemiology New York: Oxford Univ. Press. , 3rd ed..
  32. 32. 
    Rasmussen H, Holtug K, Mortensen P 1988. Degradation of amino acids to short-chain fatty acids in humans. An in vitro study. Scand. J. Gastoenterol. 23:2178–82
     [Google Scholar]
  33. 33. 
    Tapsell LC, Neale EP, Satija A, Hu FB 2016. Foods, nutrients, and dietary patterns: interconnections and implications for dietary guidelines. Adv. Nutr. 7:3445–54
     [Google Scholar]
  34. 34. 
    Sonnenburg JL, Bäckhed F. 2016. Diet-microbiota interactions as moderators of human metabolism. Nature 535:761056–64
     [Google Scholar]
  35. 35. 
    Bakker GJ, Zhao J, Herrema H, Nieuwdorp M 2015. Gut microbiota and energy expenditure in health and obesity. J. Clin. Gastroenterol. 49:S13–S19
     [Google Scholar]
  36. 36. 
    Gao Z, Yin J, Zhang J et al. 2009. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58:71509–17
     [Google Scholar]
  37. 37. 
    Chambers ES, Viardot A, Psichas A et al. 2015. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64:1744–54
     [Google Scholar]
  38. 38. 
    Layden BT, Yalamanchi SK, Wolever TM et al. 2012. Negative association of acetate with visceral adipose tissue and insulin levels. Diab. Metab. Syndr. Obes. 5:49–55
     [Google Scholar]
  39. 39. 
    Brooks L, Viardot A, Tsakmaki A et al. 2017. Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety. Mol. Metab. 6:148–60
     [Google Scholar]
  40. 40. 
    Velikonja A, Lipoglavsek L, Zorec M et al. 2018. Alterations in gut microbiota composition and metabolic parameters after dietary intervention with barley beta glucans in patients with high risk for metabolic syndrome development. Anaerobe 55:67–77
     [Google Scholar]
  41. 41. 
    Abumweis SS, Jew S, Ames NP 2010. β-Glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials. Eur. J. Clin. Nutr. 64:121472–80
     [Google Scholar]
  42. 42. 
    Korem T, Zeevi D, Zmora N et al. 2017. Bread affects clinical parameters and induces gut microbiome-associated personal glycemic responses. Cell Metab 25:61243–53.e5
     [Google Scholar]
  43. 43. 
    Malik VS, Hu FB. 2007. Popular weight-loss diets: from evidence to practice. Nat. Rev. Cardiol. 4:34–34
     [Google Scholar]
  44. 44. 
    Horton F, Wright J, Smith L et al. 2014. Increased intestinal permeability to oral chromium (51Cr)-EDTA in human Type 2 diabetes. Diab. Med. 31:5559–63
     [Google Scholar]
  45. 45. 
    Koeth RA, Lam-Galvez BR, Kirsop J et al. 2019. l-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. J. Clin. Investig. 129:1373–87
     [Google Scholar]
  46. 46. 
    Koh A, Molinaro A, Stahlman M et al. 2018. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell 175:4947–61.e17
     [Google Scholar]
  47. 47. 
    Wei S, Zhao J, Wang S et al. 2018. Intermittent administration of a leucine-deprived diet is able to intervene in type 2 diabetes in db/db mice. Heliyon 4:9e00830
     [Google Scholar]
  48. 48. 
    Jennis M, Cavanaugh CR, Leo GC et al. 2018. Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo. Neurogastroenterol. Motil. 30:2e13178
     [Google Scholar]
  49. 49. 
    Galligan JJ. 2018. Beneficial actions of microbiota-derived tryptophan metabolites. Neurogastroenterol. Motil. 30:2e13283
     [Google Scholar]
  50. 50. 
    Cani PD, Amar J, Iglesias MA et al. 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–72
     [Google Scholar]
  51. 51. 
    Higginbottom SK, Le A, Cowan TM, Nolan GP 2018. Nine circulating metabolites 551:7682648–52
  52. 52. 
    Heianza Y, Ma W, Manson JAE et al. 2017. Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta-analysis of prospective studies. J. Am. Heart Assoc. 6:7e004947
     [Google Scholar]
  53. 53. 
    Korakas E, Dimitriadis G, Raptis A, Lambadiari V 2018. Dietary composition and cardiovascular risk: a mediator or a bystander?. Nutrients 10:121912
     [Google Scholar]
  54. 54. 
    Dehghan M, Mente A, Zhang X et al. 2017. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet 390:101072050–62
     [Google Scholar]
  55. 55. 
    Haro C, Garcia-Carpintero S, Rangel-Zuniga OA et al. 2017. Consumption of two healthy dietary patterns restored microbiota dysbiosis in obese patients with metabolic dysfunction. Mol. Nutr. Food Res. 61:121700300
     [Google Scholar]
  56. 56. 
    Cani PD, Bibiloni R, Knauf C et al. 2008. Changes in gut microbiota control metabolic diet–induced obesity and diabetes in mice. Diabetes 57:1470–81
     [Google Scholar]
  57. 57. 
    Natividad JM, Lamas B, Pham HP et al. 2018. Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in mice. Nat. Commun. 9:12802
     [Google Scholar]
  58. 58. 
    Caricilli AM, Saad MJA. 2014. Gut microbiota composition and its effects on obesity and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 17:4312–18
     [Google Scholar]
  59. 59. 
    Zmora N, Bashiardes S, Levy M, Elinav E 2017. The role of the immune system in metabolic health and disease. Cell Metab 25:3506–21
     [Google Scholar]
  60. 60. 
    Thaiss CA, Zmora N, Levy M, Elinav E 2016. The microbiome and innate immunity. Nature 535:761065–74
     [Google Scholar]
  61. 61. 
    Suzuki T, Hara H. 2010. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr. Metab. 7:19
     [Google Scholar]
  62. 62. 
    Yang BG, Hur KY, Lee MS 2017. Alterations in gut microbiota and immunity by dietary fat. Yonsei Med. J. 58:61083–91
     [Google Scholar]
  63. 63. 
    Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI 2007. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. PNAS 104:3979–84
     [Google Scholar]
  64. 64. 
    Rial SA, Karelis AD, Bergeron K-F, Mounier C 2016. Gut microbiota and metabolic health: the potential beneficial effects of a medium chain triglyceride diet in obese individuals. Nutrients 8:5281
     [Google Scholar]
  65. 65. 
    Isaacs CE. 2001. The antimicrobial function of milk lipids. Adv. Nutr. Res. 10:271–85
     [Google Scholar]
  66. 66. 
    Papavassilis C, Mach KK, Mayser PA 1999. Medium-chain triglycerides inhibit growth of Malassezia: implications for prevention of systemic infection. Crit. Care Med. 27:91781–86
     [Google Scholar]
  67. 67. 
    Mumme K, Stonehouse W. 2015. Effects of medium-chain triglycerides on weight loss and body composition: a meta-analysis of randomized controlled trials. J. Acad. Nutr. Diet 115:2249–63
     [Google Scholar]
  68. 68. 
    Dinu M, Abbate R, Gensini GF et al. 2017. Vegetarian, vegan diets and multiple health outcomes: a systematic review with meta-analysis of observational studies. Crit. Rev. Food Sci. Nutr. 57:173640–49
     [Google Scholar]
  69. 69. 
    Huang T, Yang B, Zheng J 2012. Cardiovascular disease mortality and cancer incidence in vegetarians: a meta-analysis and systematic review. Ann. Nutr. Metab. 60:4233–40
     [Google Scholar]
  70. 70. 
    Rizzo G, Laganà AS, Rapisarda AMC et al. 2016. Vitamin B12 among vegetarians: status, assessment and supplementation. Nutrients 8:12767
     [Google Scholar]
  71. 71. 
    De Filippo C, Cavalieri D, Di Paola M et al. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. PNAS 107:3314691–96
     [Google Scholar]
  72. 72. 
    Smits LP, Kootte RS, Levin E et al. 2018. Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome. J. Am. Heart Assoc. 7:7e008342
     [Google Scholar]
  73. 73. 
    do Rosario VA, Fernandes R, Trindade EBS, de M 2016. Vegetarian diets and gut microbiota: important shifts in markers of metabolism and cardiovascular disease. Nutr. Rev. 74:7444–54
     [Google Scholar]
  74. 74. 
    Richter CK, Skulas-Ray AC, Champagne CM, Kris-Etherton PM 2015. Plant protein and animal proteins: Do they differentially affect cardiovascular disease risk. ? Adv. Nutr. 6:6712–28
     [Google Scholar]
  75. 75. 
    Anderson JJB, Nieman DC. 2016. Diet quality—the Greeks had it right!. Nutrients 8:10636
     [Google Scholar]
  76. 76. 
    Rosato V, Temple NJ, la Vecchia C et al. 2017. Mediterranean diet and cardiovascular disease: a systematic review and meta-analysis of observational studies. Eur. J. Nutr. 58:1173–91
     [Google Scholar]
  77. 77. 
    Kouris-Blazos A, Itsiopoulos C. 2014. Low all-cause mortality despite high cardiovascular risk in elderly Greek-born Australians: attenuating potential of diet?. Asia Pac. J. Clin. Nutr. 23:4532–44
     [Google Scholar]
  78. 78. 
    De Filippis F, Pellegrini N, Vannini L et al. 2015. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut 65:1812–21
     [Google Scholar]
  79. 79. 
    Requena T, Martinez-Cuesta MC, Pelaez C 2018. Diet and microbiota linked in health and disease. Food Funct 9:2688–704
     [Google Scholar]
  80. 80. 
    Amato KR. 2017. An introduction to microbiome analysis for human biology applications. Am. J. Hum. Biol. 29:1e22931
     [Google Scholar]
  81. 81. 
    Korpela K, Flint HJ, Johnstone AM et al. 2014. Gut microbiota signatures predict host and microbiota responses to dietary interventions in obese individuals. PLOS ONE 9:6e90702
     [Google Scholar]
  82. 82. 
    Smillie CS, Sauk J, Gevers D et al. 2018. Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell Host Microbe 23:2229–40.e5
     [Google Scholar]
  83. 83. 
    Zmora N, Zilberman-Schapira G, Suez J et al. 2018. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174:61388–405.e21
     [Google Scholar]
  84. 84. 
    Wilson BC, Vatanen T, Cutfield WS, O'Sullivan JM 2019. The super-donor phenomenon in fecal microbiota transplantation. Front. Cell Infect. Microbiol. 9: https://doi.org/10.3389/fcimb.2019.00002
     [Crossref] [Google Scholar]
  85. 85. 
    Meijnikman AS, Gerdes VE, Nieuwdorp M, Herrema H 2018. Evaluating causality of gut microbiota in obesity and diabetes in humans. Endocr. Rev. 39:2133–53
     [Google Scholar]
/content/journals/10.1146/annurev-med-062218-023720
Loading
A Crucial Role for Diet in the Relationship Between Gut Microbiota and Cardiometabolic Disease
Annual Review of Medicine 71, 149 (2020); https://doi.org/10.1146/annurev-med-062218-023720
/content/journals/10.1146/annurev-med-062218-023720
/content/journals/10.1146/annurev-med-062218-023720
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error